MIRA Pharmaceuticals to Ring the Nasdaq Opening Bell on Wednesday, August 9, 2023
BALTIMORE, Md. – MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) (“MIRA” or the “Company”), a pre-clinical-stage pharmaceutical company focused on the development and commercialization of a new synthetic THC analog with fewer side-effects and novel therapeutic potential compared to cannabis, today announced that management will participate in the Opening Bell Ceremony at the Nasdaq Stock Market on Wednesday, August 9, 2023. Erez Aminov, Chief Executive Officer of MIRA Pharmaceuticals will lead the ceremony alongside other members of the Company’s Board of Directors and management team. “This Opening Bell Ceremony is a celebration of the hard work and dedication of our team members which enabled us to be on NASDAQ and positioned us for long-term growth,” said Mr. Aminov. “Our initial drug candidate, MIRA1a, is primed for success across multiple indications as the first synthetic cannabinoid therapy that eliminates the negative side effects and impurities found in marijuana extracts. I...